Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover Bicara Therapeutics stock have a consensus rating of "Buy" and an average price target of $26.2, which forecasts a 38.48% increase in the stock price over the next year. The lowest target is $11 and the highest is $40.

Price Target: $26.2 (+38.48%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$11	$26.2	$31	$40
Change	-41.86%	+38.48%	+63.85%	+111.42%

Analyst Ratings

The average analyst rating for Bicara Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	3	3	3	3	3	1
Buy	3	3	4	4	4	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	8	8	8	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Hold Maintains $8 → $11	Hold	Maintains	$8 → $11	-41.86%	Nov 11, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $41 → $40	Strong Buy	Maintains	$41 → $40	+111.42%	Aug 22, 2025
Kelsey Goodwin Piper Sandler	Piper Sandler	Buy Initiates $36	Buy	Initiates	$36	+90.27%	Aug 19, 2025
Eva Fortea Verdejo Wells Fargo	Wells Fargo	Sell → Hold Upgrades $8	Sell → Hold	Upgrades	$8	-57.72%	May 23, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $44 → $41	Strong Buy	Maintains	$44 → $41	+116.70%	May 16, 2025

More Analyst Ratings

Financial Forecast

• Revenue This Year:
  n/a
• Revenue Next Year:
  n/a
• EPS This Year:
  -2.34

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	-	-	-	-	-	11.90M
Revenue Growth	-	-	-	-	-	-	-
EPS	-88.20	-89.61	-4.05	-2.34	-2.71	-2.68	-2.36
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	12	12	10	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-2.16	-2.06
Avg	-2.34	-2.71
Low	-2.43	-3.37

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.